High cholesterol is one of the most common and manageable risk factors for heart disease. Millions of adults are prescribed cholesterol-lowering drugs to reduce low-density lipoprotein (LDL) ...
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy.
A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...
Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...
As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...
By Dr. Sanchari Sinha Dutta, Ph.D. Three days of oat-heavy meals spark gut-derived phenolic metabolites linked to rapid ...
A large new study suggests that statins may help more people with type 2 diabetes than previously thought. Researchers found that the cholesterol-lowering drugs reduced the risk of death and serious ...